Effect of Endothelial Adhesion Molecules on Atrial Fibrillation: A Systematic Review and Meta-analysis.

Background: Endothelial adhesion molecules (EAMs), and more specifically vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), belong to a family of immunoglobulin-like molecules and are found to have increased expression in inflamed microvessels. Due to the growing evidence regarding EAM effects on cardiovascular diseases, we aimed to investigate the link between EAMs and atrial fibrillation (AF) to discover the efficacy of EAMs assessment as predictive markers in high-risk patients. Methods: We searched for articles published from January 1990 to April 2022. Two independent researchers selected studies that examined the relationship between VCAM-1 and ICAM-1 levels and AF. Study design, patient characteristics, VCAM-1 and ICAM-1 levels, and measurement methods were extracted from the selected articles. Results: Of 181 records, 22 studies were finally included in the systematic review. Meta-analyses showed a significant difference in serum levels of EAMs in patients with AF compared with patients with sinus rhythms (VCAM-1: mean difference [MD] 86.782, 95% CI 22.805-150.758, p=0.008; ICAM-1: MD 28.439 ng/mL, 95% CI 12.540-44.338, p<0.001). In subgroup analysis of persistent AF, the differences were still significant (VCAM-1: MD 98.046, 95% CI 26.582-169.510, p=0.007; ICAM-1: MD 25.091, 95% CI 12.952-37.230, p<0.001). We also found the mean ranges of VCAM-1 (95% CI 661.394-927.984 ng/mL) and ICAM-1 (95% CI 190.101-318.169 ng/mL) in patients with AF. Conclusion: This study suggests a positive association between serum levels of VCAM-1 and ICAM-1 with AF, but there is a need for further large-scale studies.

[1]  J. Pankow,et al.  Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis , 2021, BMC Cardiovascular Disorders.

[2]  G. Hindricks,et al.  Anti-inflammatory HDL effects are impaired in atrial fibrillation , 2021, Heart and Vessels.

[3]  Fernanda Sanhueza-Olivares,et al.  VCAM-1 as a predictor biomarker in cardiovascular disease. , 2021, Biochimica et biophysica acta. Molecular basis of disease.

[4]  L. Nikniaz,et al.  The relationship between preoperative serum vitamin D deficiency and postoperative atrial fibrillation: A systematic review and meta-analysis , 2021, Journal of cardiovascular and thoracic research.

[5]  A. Delago,et al.  Incidence and Mortality trends of Atrial Fibrillation/Atrial Flutter in the United States 1990 to 2017. , 2021, The American journal of cardiology.

[6]  E. Benjamin,et al.  Epidemiology of Atrial Fibrillation in the 21st Century , 2020, Circulation research.

[7]  A. Tuttolomondo,et al.  Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study , 2020, Aging.

[8]  Sanjiv J. Shah,et al.  Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life. , 2020, Journal of the American College of Cardiology.

[9]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[10]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[11]  J. Svendsen,et al.  High-sensitivity troponin I in persistent atrial fibrillation – relation to NT-proBNP and markers of inflammation and haemostasis , 2018, Scandinavian journal of clinical and laboratory investigation.

[12]  Tong Liu,et al.  Inflammation and atrial fibrillation: A comprehensive review , 2018, Journal of arrhythmia.

[13]  A. Darzi,et al.  Pre-operative serum VCAM-1 as a biomarker of atrial fibrillation after coronary artery bypass grafting , 2017, Journal of Cardiothoracic Surgery.

[14]  M. Mayr,et al.  Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation , 2017, JAMA cardiology.

[15]  C. Tufanaru,et al.  Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data , 2015, International journal of evidence-based healthcare.

[16]  W. Paulus,et al.  Atrial fibrillation coincides with the advanced glycation end product N(ε)-(carboxymethyl)lysine in the atrium. , 2015, The American journal of pathology.

[17]  V. Falk,et al.  Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients. , 2015, International journal of cardiology.

[18]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[19]  L. Boussel,et al.  Periatrial Epicardial Fat Is Associated with Markers of Endothelial Dysfunction in Patients with Atrial Fibrillation , 2013, PloS one.

[20]  G. Lip,et al.  Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[21]  N. Girerd,et al.  Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  A. Tveit,et al.  Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population , 2012, Cardiology research.

[23]  S. Ihm,et al.  Cell adhesion molecule mediation of myocardial inflammatory responses associated with ventricular pacing. , 2012, American journal of physiology. Heart and circulatory physiology.

[24]  B. Garayar,et al.  Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation. , 2011, International journal of cardiology.

[25]  S. Hohnloser,et al.  Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation , 2011, Clinical Research in Cardiology.

[26]  D. Granger,et al.  Inflammation and the Microcirculation , 2010 .

[27]  N. Cook,et al.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. , 2010, European heart journal.

[28]  Y. Iwasaki,et al.  Recruitment of immune cells across atrial endocardium in human atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[29]  R. Ding,et al.  Relation of urotensin II levels to lone atrial fibrillation. , 2009, The American journal of cardiology.

[30]  K. Channon,et al.  Preoperative sCD40L Levels Predict Risk of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery , 2009, Circulation.

[31]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[32]  A. Tuttolomondo,et al.  Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). , 2009, Clinical science.

[33]  E. Duran,et al.  The Role of Inflammation in Atrial Fibrillation following Open Heart Surgery , 2008, The Journal of international medical research.

[34]  A. Goette,et al.  Mitochondrial Dysfunction and Redox Signaling in Atrial Tachyarrhythmia , 2008, Experimental biology and medicine.

[35]  A. Goette,et al.  Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression , 2008, Circulation.

[36]  T. Yamane,et al.  Gene Expression in Endothelial Cells and Intimal Smooth Muscle Cells in Atherosclerosis-Prone or Atherosclerosis-Resistant Regions of the Human Aorta , 2008, Journal of Vascular Research.

[37]  D. Roden,et al.  Plasminogen Activator Inhibitor-1 as a Predictor of Postoperative Atrial Fibrillation After Cardiopulmonary Bypass , 2007, Circulation.

[38]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[39]  I. Hozo,et al.  Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.

[40]  H. Yip,et al.  Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis. , 2004, Chest.

[41]  C. Macías,et al.  [Endothelial adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with acute coronary syndrome]. , 2003, Revista espanola de cardiologia.

[42]  J. Danesh,et al.  Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis , 2001, The Lancet.

[43]  C. Benjamin,et al.  Structure/function studies on vascular cell adhesion molecule-1. , 1992, The Journal of biological chemistry.